Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41

被引:61
|
作者
Dennison, S. Moses [1 ]
Sutherland, Laura L. [1 ]
Jaeger, Frederick H. [1 ]
Anasti, Kara M. [1 ]
Parks, Robert [1 ]
Stewart, Shelley [1 ]
Bowman, Cindy [1 ]
Xia, Shi-Mao [1 ]
Zhang, Ruijun [1 ]
Shen, Xiaoying [1 ]
Scearce, Richard M. [1 ]
Ofek, Gilad [4 ]
Yang, Yongping [4 ]
Kwong, Peter D. [4 ]
Santra, Sampa [2 ]
Liao, Hua-Xin [1 ]
Tomaras, Georgia [1 ]
Letvin, Norman L. [2 ]
Chen, Bing [3 ]
Alam, S. Munir [1 ]
Haynes, Barton F. [1 ]
机构
[1] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Childrens Hosp,Dept Med, Boston, MA 02215 USA
[3] Harvard Univ, Childrens Hosp, Sch Med, Div Mol Med, Boston, MA 02115 USA
[4] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
来源
PLOS ONE | 2011年 / 6卷 / 11期
基金
比尔及梅琳达.盖茨基金会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; AUTOREACTIVE B-CELLS; SURFACE-ANTIGEN; VACCINE DESIGN; 2F5; EPITOPE; MEMBRANE; ENVELOPE;
D O I
10.1371/journal.pone.0027824
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A component to the problem of inducing broad neutralizing HIV-1 gp41 membrane proximal external region (MPER) antibodies is the need to focus the antibody response to the transiently exposed MPER pre-hairpin intermediate neutralization epitope. Here we describe a HIV-1 envelope (Env) gp140 oligomer prime followed by MPER peptide-liposomes boost strategy for eliciting serum antibody responses in rhesus macaques that bind to a gp41 fusion intermediate protein. This Env-liposome immunization strategy induced antibodies to the 2F5 neutralizing epitope (664)DKW residues, and these antibodies preferentially bound to a gp41 fusion intermediate construct as well as to MPER scaffolds stabilized in the 2F5-bound conformation. However, no serum lipid binding activity was observed nor was serum neutralizing activity for HIV-1 pseudoviruses present. Nonetheless, the Env-liposome prime-boost immunization strategy induced antibodies that recognized a gp41 fusion intermediate protein and was successful in focusing the antibody response to the desired epitope.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1
    Lai, Rachel P. J.
    Hock, Miriam
    Radzimanowski, Jens
    Tonks, Paul
    Hulsik, David Lutje
    Effantin, Gregory
    Seilly, David J.
    Dreja, Hanna
    Kliche, Alexander
    Wagner, Ralf
    Barnett, Susan W.
    Tumba, Nancy
    Morris, Lynn
    LaBranche, Celia C.
    Montefiori, David C.
    Seaman, Michael S.
    Heeney, Jonathan L.
    Weissenhorn, Winfried
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (43) : 29912 - 29926
  • [2] Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein
    Vassell, Russell
    He, Yong
    Vennakalanti, Prasad
    Dey, Antu K.
    Zhuang, Min
    Wang, Wei
    Sun, Yide
    Biron-Sorek, Zohar
    Srivastava, Indresh K.
    LaBranche, Celia C.
    Montefiori, David C.
    Barnett, Susan W.
    Weiss, Carol D.
    PLOS ONE, 2015, 10 (06):
  • [3] Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate Conformation
    Alam, S. Munir
    Liao, Hua-Xin
    Dennison, S. Moses
    Jaeger, Frederick
    Parks, Robert
    Anasti, Kara
    Foulger, Andrew
    Donathan, Michele
    Lucas, Judith
    Verkoczy, Laurent
    Nicely, Nathan
    Tomaras, Georgia D.
    Kelsoe, Garnett
    Chen, Bing
    Kepler, Thomas B.
    Haynes, Barton F.
    JOURNAL OF VIROLOGY, 2011, 85 (22) : 11725 - 11731
  • [4] Neutralizing Antibodies Targeting HIV-1 gp41
    Caillat, Christophe
    Guilligay, Delphine
    Sulbaran, Guidenn
    Weissenhorn, Winfried
    VIRUSES-BASEL, 2020, 12 (11):
  • [5] Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads
    Caulfield, Michael J.
    Dudkin, Vadim Y.
    Ottinger, Elizabeth A.
    Getty, Krista L.
    Zuck, Paul D.
    Kaufhold, Robin M.
    Hepler, Robert W.
    McGaughey, Georgia B.
    Citron, Michael
    Hrin, Renee C.
    Wang, Ying-Jie
    Miller, Michael D.
    Joyce, Joseph G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (52) : 40604 - 40611
  • [6] Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies
    Frey, Gary
    Chen, Jia
    Rits-Volloch, Sophia
    Freeman, Michael M.
    Zolla-Pazner, Susan
    Chen, Bing
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (12) : 1486 - U118
  • [7] Development of HIV-1 Fusion Inhibitors Targeting gp41
    Lu, K.
    Asyifah, M. R.
    Shao, F.
    Zhang, D.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (17) : 1976 - 1996
  • [8] Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
    Lee, Jeong Hyun
    Leaman, Daniel P.
    Kim, Arthur S.
    de la Pena, Alba Torrents
    Sliepen, Kwinten
    Yasmeen, Anila
    Derking, Ronald
    Ramos, Alejandra
    de Taeye, Steven W.
    Ozorowski, Gabriel
    Klein, Florian
    Burton, Dennis R.
    Nussenzweig, Michel C.
    Poignard, Pascal
    Moore, John P.
    Klasse, Per Johan
    Sanders, Rogier W.
    Zwick, Michael B.
    Wilson, Ian A.
    Ward, Andrew B.
    NATURE COMMUNICATIONS, 2015, 6
  • [9] HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies
    Wang, Ji
    Tong, Pei
    Lu, Lu
    Zhou, Leilei
    Xu, Liling
    Jiang, Shibo
    Chen, Ying-hua
    PLOS ONE, 2011, 6 (03):
  • [10] Characterization of a trimeric MPER containing HIV-1 gp41 antigen
    Hinz, Andreas
    Schoehn, Guy
    Quendler, Heribert
    Hulsik, David Lutje
    Stiegler, Gabi
    Katinger, Hermann
    Seaman, Michael S.
    Montefiori, David
    Weissenhorn, Winfried
    VIROLOGY, 2009, 390 (02) : 221 - 227